// App-Quantinova.ai

445 : Association between sites of metastases (mets) and outcomes with immune checkpoint inhibitor (ICI) therapy for advanced urothelial carcinoma (aUC).

Researchers

Presenter

  • Dimitrios Makrakis

Principal Investigators

  • Vadim S Koshkin

  • Ajjai Shivaram Alva

  • Mehmet Asim Bilen

  • Tyler Francis Stewart

  • Victor Sacristan Santos

  • Jayanshu Jain

  • Rafael Morales-Barrera

  • Michael E. Devitt

  • Lucia Carril-Ajuria

  • Ariel Ann Nelson

  • Alexander Sankin

  • Roubini Zakopoulou

  • David James Pinato

  • Ana Frbe

  • Monika Joshi

  • Guru Sonpavde

  • Petros Grivas

  • Ali Raza Khaki

Medical Centers

  • University of Washington School of Medicine, Seattle, WA

  • University of Pittsburgh Medical Center, Pittsburgh, PA

  • Division of Hematology/Oncology, Department of Medicine, University of California, Irvine, Orange, CA

  • University of Michigan Comprehensive Cancer Center, Ann Arbor, MI

  • Department of Hematology and Medical Oncology, Emory University School of Medicine, Atlanta, GA

  • Yale New Haven Hospital, New Haven, CT

  • Division of Inpatient Medicine, University of Utah, Salt Lake City, UT

  • Department of Medicine, University of Iowa Health Care, Iowa City, IA

  • Vall d'Hebron Institute of Oncology, Barcelona, Spain

  • University of Virgina, Charlottesville, VA

  • Department of Dermatology, Hospital Universitario 12 de Octubre, Madrid, Spain

  • The Medical College of Wisconsin, Milwaukee, WI

  • Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY

  • Hellenic Cooperative Oncology Group (HeCOG), Athens, Greece

  • Department of Surgery & Cancer, Imperial College London, London, United Kingdom

  • Department of Oncology University Hospital Center Sisters of Mercy University of Zagreb Medical School, Zagreb, Croatia

  • Penn State Cancer Institute, Hershey, PA

  • Dana-Farber Cancer Institute and Harvard Medical School, Boston, MA

  • University of Washington, Seattle, WA

Locations

  • United States

  • Spain

  • Greece

  • United Kingdom

  • Croatia

Companies

  • N/A

Study Components

Therapeutic Area

  • Genetic Disorder

  • Musculoskeletal

Disease

  • Advanced Urothelial Carcinoma

  • Short stature, onychodysplasia, facial dysmorphism, and hypotrichosis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved